Advanced Lung Disease Conference 2020
S

Management of Acute ILD Exacerbation (AE-IPF): Does Rituximab Provide Beneficial Effects for IPF Patients? What Is the Efficacy of Autoantibody Reduction Therapies?

By Advanced Lung Disease Conference 2020 FEATURING Steven Duncan
By Advanced Lung Disease Conference 2020 FEATURING Steven Duncan
668 views
February 2, 2021
Comments 1
Login to view comments. Click here to Login

Featured Video

39:42
Boehringer Ingelheim

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Featured Video

28:46
Boehringer Ingelheim

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Recommended

57:16

New

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

41 views
51:53

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

12.7K views
16:13

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

8.8K views
53:31

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

7.0K views
19:21

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

5.3K views
28:18

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

4.4K views
52:53

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

4.3K views
24:02

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

5.0K views
21:34

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

4.8K views
25:48

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

3.8K views
40:52

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

179 views
09:19

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

3.2K views
33:57

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

2.6K views
18:52

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

49 views
16:51

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

100 views
27:38

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

650 views
26:15

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Weichhart

52 views
46:24

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

3.3K views
12:52

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

The France Foundation

V. Khangoora

529 views
16:54

Lymphangioleiomyomatosis: A Clinical Overview

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

F. Mccormack

1.1K views
AUTOPLAY